Business
Innate Pharma Releases Its 2026 Financial Calendar
MARSEILLE, France, December 11, 2025--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today released its 2026 financial calendar:
About this update from Innate Pharma Sa Class A
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/65670e8a5c7952d8c6ec33cd3e42f7fa"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YKXR5hJmukvJ200o7SrGnA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/65670e8a5c7952d8c6ec33cd3e42f7fa","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/yogjyl3RyYP4EzpqPVucsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/65670e8a5c7952d8c6ec33cd3e42f7fa","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MARSEILLE, France, December 11, 2025--(BUSINESS WIRE)--Regulatory News:","length":71,"tagName":"p"},{"type":"text","content":"Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today released its 2026 financial calendar:","length":144,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"March 26, 2026: Publication of 2025 financial statements","length":56,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"May 13, 2026: Publication of revenue and cash position for 1Q2026","length":65,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"May 21, 2026: Annual General Shareholders Meeting","length":49,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"September 17, 2026: Publication of half year financial statements","length":65,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"November 5, 2026: Publication of revenue and cash position for 3Q2026","length":69,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":304,"olType":false},{"type":"text","content":"All financial reports are released before market opens CET.","length":59,"tagName":"p"},{"type":"text","content":"All corporate information, such as the Company’s financial statements and corporate presentations, is available on the Investors section on the Company website.","length":160,"tagName":"p"},{"type":"text","content":"About Innate Pharma","length":19,"tagName":"p"},{"type":"text","content":"Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patien...